Uniyal P, Kashyap V, Behl T, Parashar D, Rawat R
Cancers (Basel). 2025; 17(5).
PMID: 40075634
PMC: 11899378.
DOI: 10.3390/cancers17050785.
Deck S, Xu M, Milano S, Cerione R
bioRxiv. 2025; .
PMID: 40060414
PMC: 11888411.
DOI: 10.1101/2025.02.27.639303.
Li J, Liu H, Li J, Liu J, Dai X, Zhu A
Nat Commun. 2025; 16(1):2054.
PMID: 40021629
PMC: 11871024.
DOI: 10.1038/s41467-025-57152-7.
Peng Z, Xu S, Wang H, Huang Y, Liu S, Jiao Z
Oncol Lett. 2025; 29(4):178.
PMID: 39990806
PMC: 11843412.
DOI: 10.3892/ol.2025.14924.
Pape B, Parate S, Eriksson L, Jha V
Biochemistry. 2025; 64(5):1006-1019.
PMID: 39947931
PMC: 11883811.
DOI: 10.1021/acs.biochem.4c00562.
The small GTPases FoRab5, FoRab7, and FoRab8 regulate vesicle transport to modulate vegetative development and pathogenicity in f. sp. .
Tan X, Chen L, Chen Y, Li Y, Lu L, Li E
Front Microbiol. 2025; 16:1514092.
PMID: 39944649
PMC: 11814470.
DOI: 10.3389/fmicb.2025.1514092.
Elucidating the therapeutic potential of indazole derivative bindarit against K-ras receptor: An analysis using molecular dynamics exploration.
Nandan P, Sivaraman J
Biochem Biophys Rep. 2025; 41:101913.
PMID: 39867680
PMC: 11758134.
DOI: 10.1016/j.bbrep.2024.101913.
Advancements in gene therapies targeting mutant KRAS in cancers.
Wang Y, Bui T, Yang X, Hutvagner G, Deng W
Cancer Metastasis Rev. 2025; 44(1):24.
PMID: 39820726
PMC: 11748474.
DOI: 10.1007/s10555-025-10243-9.
Structural Dynamics of Rho GTPases.
Lin Y, Zheng Y
J Mol Biol. 2024; 437(3):168919.
PMID: 39708912
PMC: 11757035.
DOI: 10.1016/j.jmb.2024.168919.
Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism.
Gilsbach B, Ho F, Riebenbauer B, Zhang X, Guaitoli G, Kortholt A
Elife. 2024; 12.
PMID: 39699947
PMC: 11658767.
DOI: 10.7554/eLife.91083.
New insights into protein-protein interaction modulators in drug discovery and therapeutic advance.
Nada H, Choi Y, Kim S, Jeong K, Meanwell N, Lee K
Signal Transduct Target Ther. 2024; 9(1):341.
PMID: 39638817
PMC: 11621763.
DOI: 10.1038/s41392-024-02036-3.
Structural basis for Rab6 activation by the Ric1-Rgp1 complex.
Feathers J, Vignogna R, Fromme J
Nat Commun. 2024; 15(1):10561.
PMID: 39632878
PMC: 11618376.
DOI: 10.1038/s41467-024-54869-9.
Regulation of formin INF2 and its alteration in INF2-linked inherited disorders.
Labat-de-Hoz L, Jimenez M, Correas I, Alonso M
Cell Mol Life Sci. 2024; 81(1):463.
PMID: 39586895
PMC: 11589041.
DOI: 10.1007/s00018-024-05499-3.
Lateral nanoarchitectonics from nano to life: ongoing challenges in interfacial chemical science.
Song J, Jancik-Prochazkova A, Kawakami K, Ariga K
Chem Sci. 2024; 15(45):18715-18750.
PMID: 39568623
PMC: 11575615.
DOI: 10.1039/d4sc05575f.
Motif-guided identification of KRAS-interacting proteins.
Wu S, Gao X, Wu D, Liu L, Yao H, Meng X
BMC Biol. 2024; 22(1):264.
PMID: 39563372
PMC: 11575137.
DOI: 10.1186/s12915-024-02067-w.
Landscape of targeted therapies for lung squamous cell carcinoma.
Chen Q, Zheng X, Cheng W, Li J
Front Oncol. 2024; 14:1467898.
PMID: 39544292
PMC: 11560903.
DOI: 10.3389/fonc.2024.1467898.
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms.
Yang X, Wu H
J Hematol Oncol. 2024; 17(1):108.
PMID: 39522047
PMC: 11550559.
DOI: 10.1186/s13045-024-01631-9.
Pharmacological restoration of GTP hydrolysis by mutant RAS.
Cuevas-Navarro A, Pourfarjam Y, Hu F, Rodriguez D, Vides A, Sang B
Nature. 2024; 637(8044):224-229.
PMID: 39476862
PMC: 11666464.
DOI: 10.1038/s41586-024-08283-2.
A noncanonical GTPase signaling mechanism controls exit from mitosis in budding yeast.
Zhou X, Weng S, Bell S, Amon A
Proc Natl Acad Sci U S A. 2024; 121(45):e2413873121.
PMID: 39475649
PMC: 11551315.
DOI: 10.1073/pnas.2413873121.
Advances and Challenges in RAS Signaling Targeted Therapy in Leukemia.
Chen Y, Yin Z, Westover K, Zhou Z, Shu L
Mol Cancer Ther. 2024; 24(1):33-46.
PMID: 39404173
PMC: 11694067.
DOI: 10.1158/1535-7163.MCT-24-0504.